Munich-Planegg (Urologische Klinik München-Planegg), the private urology hospital in Munich (Germany), has expressed its readiness to join the Moscow International Medical Cluster. The hospital is negotiating with the IMC Foundation a project of an Urology Centre in the cluster.
Munich-Planegg is the largest private urology hospital in Germany which provides a full range of medical services in the area of urology and andrology. The hospital was founded in 1970 and nowadays it has modern medical equipment for diagnosis, surgical and non-surgical treatment of patients with full range of urologic diseases (oncology, nephrology, andrology etc.). The Munich-Planegg hospital is certified according to DIN and ISO 9001 standards.
Since 2009, the hospital has been certified in Bavaria as a Medical Centre specializing in treatment of patients with benign and malignant prostate tumors and a Medical Centre for urolithiasis treatment. The medical services provided by the Munich-Planegg hospital include transurethral resection of tumors, chemotherapy, radiotherapy, reconstructive plastic bladder and ureters surgeries, radical and non-radical genitourinary surgeries. To perform the most complicated prostate, kidney, bladder surgeries, methods involving the da Vinci Surgical System are used.
Every year, about 10,000 patients are treated at Munich-Planegg hospital, of which 3,000 receive inpatient treatment. In 2016, 2,574 surgeries were performed in the five operating theaters of the hospital.
Employees of the Munich-Planegg urology hospital regularly take part in international congresses symposiums, organize round-table discussions and workshops, as well as courses of continuing medical education for German urologists and lectures at the Ludwig Maximilian University of Munich.
The Munich-Planegg urology hospital is considering to establish 5,000 sq m Urology Centre in the Moscow International Medical Cluster, which will meet German standards of medical care. In accordance with the preliminary plan, the Urology Centre will have 85 beds (including 15 ICU beds).
The Urology Centre will have advanced medical equipment to diagnose and treat patients with different urologic diseases, including cancer. The Centre is planned to provide treatment for about 4,500 patients during the first year of its operation and for up to 10,000 patients by the fourth year.
Munich-Planegg urology hospital has expressed readiness to organize continuing medical education and advanced professional development courses for Russian specialists both in the Munich-Planegg urology hospital and in the new Urology Centre in Moscow.
"Modern urology is so advanced that it is possible to diagnose any urologic diseases very quickly and effectively. Munich-Planegg is among well-known leaders not only in services provided, but also in the development of innovative treatment methods. This is why the interest in a cluster of organizations of such a level is extremely important for us," emphasized CEO of the IMC Foundation Mikhail Yugay.
The Moscow International Medical Cluster (MIMC) is a large medical infrastructure project in Russia aimed at developing the national healthcare ecosystem. It was established and is supervised by the Moscow Government. The Cluster is being built on the territory of the Skolkovo Innovation Centre, on a total area of 57 hectares of land leased from it.
In 2017 the IMC Foundation launched an international roadshow to attract medical operators and investors. By 2029, the cluster plans to host 15 centres of excellence, an education centre and a research centre, and the infrastructure for accommodating patients and medical professionals.
The cluster's activities are regulated by the Federal Law "On the International Medical Cluster" No.160-FZ which allows clinics from developed OECD countries to provide medical care, use pharmaceuticals and equipment in accordance with the standards of their countries in the cluster without obtaining additional permits in Russia.